Cargando…
Choroidal thickness as a possible predictor of non-response to intravitreal bevacizumab for macular edema after retinal vein occlusion
To evaluate outcomes of intravitreal bevacizumab (IVB) treating macular edema (ME) after retinal vein occlusion (RVO) following pro re nata (PRN) regimen and investigate potential predictors of non-response. Retrospective analysis of 126 treatment-naive eyes with ME after RVO. Eyes were treated init...
Autores principales: | Aljundi, Wissam, Gradinger, Florian, Langenbucher, Achim, Sideroudi, Haris, Seitz, Berthold, Abdin, Alaa Din |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9829912/ https://www.ncbi.nlm.nih.gov/pubmed/36624124 http://dx.doi.org/10.1038/s41598-023-27753-7 |
Ejemplares similares
-
Intravitreal Injection for Diabetic Macular Edema as Adjunctive Therapy for Proliferative Diabetic Retinopathy: A Retrospective Study
por: Aljundi, Wissam, et al.
Publicado: (2022) -
First Year Real Life Experience With Intravitreal Brolucizumab for Treatment of Refractory Neovascular Age-Related Macular Degeneration
por: Abdin, Alaa Din, et al.
Publicado: (2022) -
Topical NSAIDs and Oral Acetazolamide for Macular Edema after Uncomplicated Phacoemulsification: Outcome and Predictors of Non-Response
por: Aljundi, Wissam, et al.
Publicado: (2022) -
Intravitreal aflibercept following treat and extend protocol versus fixed protocol for treatment of neovascular age-related macular degeneration
por: Abdin, Alaa Din, et al.
Publicado: (2021) -
Recurrent fungal endophthalmitis after intravitreal injections of bevacizumab
por: Abdin, Alaa Din, et al.
Publicado: (2020)